Cancer cachexia: Diagnosis, assessment, and treatment

被引:152
作者
Sadeghi, Mohammadamin [1 ,2 ,3 ]
Keshavarz-Fathi, Mahsa [2 ,3 ]
Baracos, Vickie [4 ]
Arends, Jann [5 ]
Mahmoudi, Maryam [2 ,6 ,7 ]
Rezaei, Nima [8 ,9 ,10 ]
机构
[1] USERN, MMIG, Tehran, Iran
[2] USERN, CIP, Tehran, Iran
[3] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[4] Univ Alberta, Dept Oncol, Div Palliat Care Med, Edmonton, AB, Canada
[5] Univ Freiburg, Fac Med, Dept Med 1, Med Ctr, Freiburg, Germany
[6] USERN, Dietitians & Nutr Experts Team DiNET, Tehran, Iran
[7] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Cellular & Mol Nutr, Tehran, Iran
[8] Univ Tehran Med Sci, Childrens Med Ctr, Res Ctr Immunodeficiencies, Tehran, Iran
[9] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran
[10] USERN, CIP, Sheffield, S Yorkshire, England
关键词
Cancer cachexia; Nutrition; Palliative medicine; Biomarker; Pharmacologic treatment; Nutritional treatment; Exercise; Psychological treatment; QUALITY-OF-LIFE; CELL LUNG-CANCER; PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; MINI NUTRITIONAL ASSESSMENT; LEAN BODY-MASS; DIFFERENT ASSESSMENT CRITERIA; SUBJECTIVE GLOBAL ASSESSMENT; HYPOTHALAMIC NEUROPEPTIDE-Y; SKELETAL-MUSCLE MASS;
D O I
10.1016/j.critrevonc.2018.05.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer cachexia is a multi-factorial syndrome, which negatively affects quality of life, responsiveness to chemotherapy, and survival in advanced cancer patients. Our understanding of cachexia has grown greatly in recent years and the roles of many tumor-derived and host-derived compounds have been elucidated as mediators of cancer cachexia. However, cancer cachexia remains an unmet medical need and attempts towards a standard treatment guideline have been unsuccessful. This review covers the diagnosis, assessment, and treatment of cancer cachexia; the elements impeding the formulation of a standard management guideline; and future directions of research for the improvement and standardization of current treatment procedures.
引用
收藏
页码:91 / 104
页数:14
相关论文
共 286 条
[31]   Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients [J].
Bosaeus, I ;
Daneryd, P ;
Svanberg, E ;
Lundholm, K .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (03) :380-383
[32]  
Bovio G, 2008, Minerva Gastroenterol Dietol, V54, P243
[33]   Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results [J].
Bozzetti, Federico .
CLINICAL NUTRITION, 2013, 32 (05) :876-876
[34]   Is the intravenous supplementation of amino acid to cancer patients adequate? A critical appraisal of literature [J].
Bozzetti, Federico ;
Bozzetti, Valentina .
CLINICAL NUTRITION, 2013, 32 (01) :142-146
[35]   Defining and Classifying Cancer Cachexia: A Proposal by the SCRINIO Working Group [J].
Bozzetti, Federico ;
Mariani, Luigi .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2009, 33 (04) :361-367
[36]   Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: A double-blind, placebo-controlled study [J].
Bruera, E ;
Strasser, F ;
Palmer, JL ;
Willey, J ;
Calder, K ;
Amyotte, G ;
Baracos, V .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :129-134
[37]  
BRUERA E, 1985, CANCER TREAT REP, V69, P751
[38]   Low Testosterone Levels and Increased Inflammatory Markers in Patients with Cancer and Relationship with Cachexia [J].
Burney, Basil O. ;
Hayes, Teresa G. ;
Smiechowska, Joanna ;
Cardwell, Gina ;
Papusha, Victor ;
Bhargava, Peeyush ;
Konda, Bhavana ;
Auchus, Richard J. ;
Garcia, Jose M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (05) :E700-E709
[39]   Anticachectic effects of formoterol:: A drug for potential treatment of muscle wasting [J].
Busquets, S ;
Figueras, MT ;
Fuster, G ;
Almendro, V ;
Moore-Carrasco, R ;
Ametller, E ;
Argilés, JM ;
López-Soriano, FJ .
CANCER RESEARCH, 2004, 64 (18) :6725-6731
[40]   Alterations in inflammatory biomarkers and energy intake in cancer cachexia: a prospective study in patients with inoperable pancreatic cancer [J].
Bye, Asta ;
Wesseltoft-Rao, Nima ;
Iversen, Per Ole ;
Skjegstad, Grete ;
Holven, Kirsten B. ;
Ulven, Stine ;
Hjermstad, Marianne J. .
MEDICAL ONCOLOGY, 2016, 33 (06)